Welcome to Eisai, India. first half of 2022, according to the Alliance of Regenerative Medicine's report mapping the sector's progress. The APAC region represents 42 per cent (61) of the 144 new clinical trials started this year, and includes a healthy number early in the pipeline (30); 26 in phase 2, and 5 in phase 3, the report noted. All pages (A3-sized) All pages (A4-sized) Cover. Copyright Eisai Co., Ltd. All Rights Reserved. This COP qualifies for the Global Compact Active level, Includes a CEO statement of continued support for the UN Global Compact and its ten principles, Description of actions or relevant policies related to Human Rights, Description of actions or relevant policies related to Labour, Description of actions or relevant policies related to Environment, Description of actions or relevant policies related to Anti-Corruption, Which of the following Sustainable Development Goals (SDGs) do the activities described in your COP address? 2018 Integrated Report 7.8 MB. The organization and its reporting practices, Entities included in the organizations sustainability reporting, Reporting period, frequency and contact point, Activities, value chain and other business relationships, Nomination and selection of the highest governance body, Role of the highest governance body in overseeing the management of impacts, Delegation of responsibility for managing impacts, Role of the highest governance body in sustainability reporting, Collective knowledge of the highest governance body, Evaluation of the performance of the highest governance body, Statement on sustainable development strategy, Mechanisms for seeking advice and raising concerns, Direct economic value generated and distributed, Financial implications and other risks and opportunities due to climate change, Defined benefit plan obligations and other retirement plans, Financial assistance received from government, Ratios of standard entry level wage by gender compared to local minimum wage, Proportion of senior management hired from the local community, Infrastructure investments and services supported, Proportion of spending on local suppliers, Operations assessed for risks related to corruption, Communication and training about anti-corruption policies and procedures, Confirmed incidents of corruption and actions taken, Legal actions for anti-competitive behavior, anti-trust, and monopoly practices, Tax governance, control, and risk management, Stakeholder engagement and management of concerns related to tax, Reclaimed products and their packaging materials, Energy consumption within the organization, Energy consumption outside of the organization, Reductions in energy requirements of products and services, Interactions with water as a shared resource, Management of water discharge-related impacts, Operational sites owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas, Significant impacts of activities, products, and services on biodiversity, IUCN Red List species and national conservation list species with habitats in areas affected by operations, Emissions of ozone-depleting substances (ODS), Nitrogen oxides (NOX), sulfur oxides (SOX), and other significant air emissions, Waste generation and significant waste-related impacts, Management of significant waste-related impacts, Non-compliance with environmental laws and regulations, New suppliers that were screened using environmental criteria, Negative environmental impacts in the supply chain and actions taken, Benefits provided to full-time employees that are not provided to temporary or part-time employees, Minimum notice periods regarding operational changes, Occupational health and safety management system, Hazard identification, risk assessment, and incident investigation, Worker participation, consultation, and communication on occupational health and safety, Worker training on occupational health and safety, Prevention and mitigation of occupational health and safety impacts directly linked by business relationships, Workers covered by an occupational health and safety management system, Average hours of training per year per employee, Programs for upgrading employee skills and transition assistance programs, Percentage of employees receiving regular performance and career development reviews, Diversity of governance bodies and employees, Ratio of basic salary and remuneration of women to men, Incidents of discrimination and corrective actions taken, Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk, Operations and suppliers at significant risk for incidents of child labor, Operations and suppliers at significant risk for incidents of forced or compulsory labor, Security personnel trained in human rights policies or procedures, Incidents of violations involving rights of indigenous peoples, Operations that have been subject to human rights reviews or impact assessments, Employee training on human rights policies or procedures, Significant investment agreements and contracts that include human rights clauses or that underwent human rights screening, Operations with local community engagement, impact assessments, and development programs, Operations with significant actual and potential negative impacts on local communities, New suppliers that were screened using social criteria, Negative social impacts in the supply chain and actions taken, Assessment of the health and safety impacts of product and service categories, Incidents of non-compliance concerning the health and safety impacts of products and services, Requirements for product and service information and labeling, Incidents of non-compliance concerning product and service information and labeling, Incidents of non-compliance concerning marketing communications, Substantiated complaints concerning breaches of customer privacy and losses of customer data, Non-compliance with laws and regulations in the social and economic area. 'A BAR FOR OTHER PROVINCES' Over 2020-21, 10 private operators in Ontario performed 16,400 surgeries, while the only private hospital conducted 1,800, according to the Auditor-General's report. Integrated Report 2018; Presentations. Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of its annual Drugs to Watch report. The Texas Integrated Report describes the status of the state's waters, as required by Sections 305(b) and 303(d) of the federal Clean Water Act. Eisai (OTCPK:ESALF): Q1 GAAP EPS of 85.20.Revenue of 165.58B (+7.5% Y/Y)Press Release . (For our 2021 Integrated Report, please click here .) This website uses cookies to enhance your browsing experience. As shown in Figure 2, at a 95% confidence rate (p < 0.05 . Engineer with experience in design, quality assurance, and regulatory affairs of medical devices with an emphasis on the safe and secure end-user experience. Percentage of employees receiving regular performance and career development reviews. Use a + to require a term in results and - to exclude terms. SAP Integrated Report 2021 (PDF) SAP Annual Report on Form 20-F 2021 (PDF) Chart Generator and Data Download. GRI 405: Diversity and Equal Opportunity 2016. Integrated Report 2020 PDF | 18,434 KB. 405-1. Apr 2015 - Present7 years 10 months. Under this Philosophy, the Company endeavors to become a human health care (hhc) company. Read more, Medium-Term Business Plan EWAY Future & Beyond, Basic Policies Regarding Persons to Control the Determination of Financial and Business Policies of the Company, Value Creation Report / Environmental Report, Initiatives for Sustainable Development Goals, Member Organizations and Initiatives That Engage in Sustainability-Related Activities, Initiatives for the Formation of a Carbon-free Society, Establishment of a Recycling-Oriented Society, Relationship with Industry Associations and Patient Groups (Advocacy), Relationship with People throughout Society, Production and Logistics (Demand Chain Systems), EISAI LISTED AS A GLOBAL 100 MOST SUSTAINABLE CORPORATION FOR THE SEVENTH TIME, EISAI AIMS TO ADVANCE GASTROINTESTINAL CANCER TREATMENT WITH RESEARCH ACROSS MULTIPLE TUMOR TYPES AT ASCO GI 2023, Wednesday, November 30, 2022 09:50 a.m.- (JST). Initiatives for Improving Access to Medicines. Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that it was selected as one of winners of the . 2019 Integrated Report 8.1 MB. Eisai's commitment to healthcare began in Japan in 1941. FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 Archive. Ronak Patel is an Associate Director of Scientific Engagement and Digital Communications on Eisai's US Medical Affairs team. Eisai contributes to the sustainability of society through ESG (Environmental, Social, Governance) initiatives. The Group recorded 34.5 billion (20.7 billion in the same period of the previous fiscal year) as sales milestone . Product Owner for Eisai's first on-demand web platform for HCPs. Copyright Eisai Co., Ltd. All Rights Reserved. Introduction 2021 U.S. Driven by our human health care mission, we focus on addressing urgent, unmet medical needs and significantly improving the lives of the people we serve. Read more, Medium-Term Business Plan EWAY Future & Beyond, Basic Policies Regarding Persons to Control the Determination of Financial and Business Policies of the Company, Value Creation Report / Environmental Report, Initiatives for Sustainable Development Goals, Member Organizations and Initiatives That Engage in Sustainability-Related Activities, Initiatives for Elimination of Neglected Tropical Diseases, Initiatives for Improving Access to Medicines for Non-communicable Diseases, Research & Development for Improving Access to Medicines, Initiatives for the Formation of a Carbon-free Society, Establishment of a Recycling-Oriented Society, Relationship with Industry Associations and Patient Groups (Advocacy), Relationship with People throughout Society, Production and Logistics (Demand Chain Systems), CONSOLIDATED FINANCIAL REPORT [IFRS]for Fiscal 2021 (Year Ended March 31, 2021), FY 2021 (Ended March 31, 2022) Full Year Financial Results Reference Data, Promotion Structure and Internal Audits of Environmental Management, (In Japanese) 110p.50-, (In Japanese)110p.50-, (In Japanese)110p.53-, (In Japanese)110p.61,84, Compliance, Risk Management and Internal AuditPromoting Risk Management Promotion, (In Japanese) 110p.58-61, (In Japanese) 110p.55-56, (In Japanese) 110p.91-94, (In Japanese) , (In Japanese) , Compliance, Risk Management and Internal Audit, Respect for Human RightsHuman rights of employees, CONSOLIDATED FINANCIAL REPORT [IFRS]for Fiscal 2021 (Year Ended March 31, 2022), CONSOLIDATED FINANCIAL REPORT [IFRS]for Fiscal 2021 (Year Ended March 31, 2022) p.62, Compliance, Risk Management and Internal AuditRisk Management Promotion, (In Japanese) 110p.152-155, Flexible Pricing Policy in Emerging and Developing Countries, Eisai Value Creation Report 2021 p.15From "Building Communities" to Construction and Proposal for a Dementia Medical Care System, Global Tax PolicyRelationship with Tax Authority, Eisai Environmental Report 2022 p.3, 5, 10, 12, Eisai Environmental Report 2022 p.4, 9, 11, Eisai Environmental Report 2022 p.5, 17-19, Eisai Environmental Report 2022 p.5, 9-12, Eisai Environmental Report 2022 p.5, 911, Eisai Environmental Report 2022 p.14, 15, 17-19, Eisai Environmental Report 2022 p.5, 13-15, Eisai Environmental Report 2022 p.7, 8, 13-15, Eisai Environmental Report 2022 p.5, 13, 18, 19, Eisai Value Creation Report 2022 p.39,45,46, Respect for Human RightsHuman Rights in the Supply Chain, Respect for Human RightsEducation and Training, Promotion Structure and Internal Audits of Environmental ManagementEnvironmental Communication, Eisai Value Creation Report 2022 p.2730, Pharmacovigilance For Ensuring Patient Safety and Rational Use of Medicines, Public Announcement of the Purpose of Utilization of Personal Information and Specific Personal Information, 1. Hong Kong Life Sciences Society (HKLSS) is an organisation established in 2018 aiming to build a dynamic life sciences ecosystem in Hong Kong. DEP encourages the public to provide constructive comments during this period. Jun 2020 - Jan 20221 year 8 months. SDG 1: End poverty in all its forms everywhere, SDG 2: End hunger, achieve food security and improved nutrition and promote sustainable agriculture, SDG 3: Ensure healthy lives and promote well-being for all at all ages, SDG 4: Ensure inclusive and equitable quality education and promote lifelong learning opportunities for all, SDG 5: Achieve gender equality and empower all women and girls, SDG 6: Ensure availability and sustainable management of water and sanitation for all, SDG 7: Ensure access to affordable, reliable, sustainable and modern energy for all, SDG 8: Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all, SDG 9: Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation, SDG 10: Reduce inequality within and among countries, SDG 11: Make cities and human settlements inclusive, safe, resilient and sustainable, SDG 12: Ensure sustainable consumption and production patterns, SDG 13: Take urgent action to combat climate change and its impacts, SDG 14: Conserve and sustainably use the oceans, seas and marine resources for sustainable development, SDG 15: Protect, restore and promote sustainable use of terrestrial ecosystems, sustainably manage forests, combat desertification, and halt and reverse land degradation and halt biodiversity loss, SDG 16: Promote peaceful and inclusive societies for sustainable development, provide access to justice for all and build effective, accountable and inclusive institutions at all levels, SDG 17: Strengthen the means of implementation and revitalize the global partnership for sustainable development, Opportunities and responsibilities that one or more SDGs represent to our business, Where the companys priorities lie with respect to one or more SDGs, Goals and indicators set by our company with respect to one or more SDGs, How one or more SDGs are integrated into the companys business model, The (expected) outcomes and impact of your companys activities related to the SDGs, If the companies' activities related totheSDGs are undertaken in collaboration with other stakeholders, Other established or emerging best practices. Read more, Medium-Term Business Plan EWAY Future & Beyond, Basic Policies Regarding Persons to Control the Determination of Financial and Business Policies of the Company, Value Creation Report / Environmental Report, Initiatives for Sustainable Development Goals, Member Organizations and Initiatives That Engage in Sustainability-Related Activities, Initiatives for Elimination of Neglected Tropical Diseases, Initiatives for Improving Access to Medicines for Non-communicable Diseases, Research & Development for Improving Access to Medicines, Initiatives for the Formation of a Carbon-free Society, Establishment of a Recycling-Oriented Society, Relationship with Industry Associations and Patient Groups (Advocacy), Relationship with People throughout Society, Production and Logistics (Demand Chain Systems), EISAI COMPLETES CONSTRUCTION OF THE 5TH MANUFACTURING BUILDING AT KAWASHIMA INDUSTRIAL PARK IN JAPAN, LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Demonstrated Statistically Significant Improvement in Overall Survival, Progression-Free Survival and Objective Response Rate Versus Chemotherapy in Patients With Advanced Endometrial Cancer Following Prior Systemic Therapy in Phase 3 Study, BIOGEN FILES NEW DRUG APPLICATION FOR ADUCANUMAB IN JAPAN, EISAI AND WREN THERAPEUTICS ENTER INTO RESEARCH COLLABORATION AGREEMENT FOR DRUG DISCOVERY FOR SYNUCLEINOPATHIES, EISAI COMMENCES PaDiCo SMARTPHONE APPLICATION SERVICE IN JAPAN TO SUPPORT THE DAILY LIVES OF PATIENTS WITH PARKINSONS DISEASE, JYSELECA (FILGOTINIB) FOR RHEUMATOID ARTHRITIS LAUNCHES IN JAPAN, LENVIMA Plus KEYTRUDA Demonstrated Statistically Significant Improvement in Progression-Free Survival, Overall Survival and Objective Response Rate Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma, Sysmex Presents Academic Report with a View to Creating a Simple Method of Diagnosing Alzheimers Disease Using Blood, European Medicines Agency Accepts Biogens Aducanumab Marketing Authorization Application for Alzheimer's Disease, EISAI AND JD HEALTH ESTABLISH A JOINT VENTURE COMPANY IN CHINA TO IMPLEMENT HEALTH SERVICE PLATFORM, GLOBAL COALITION FOR ADAPTIVE RESEARCH, AMGEN, AND EISAI ANNOUNCE FIRST PATIENT ENROLLED IN INTERNATIONAL COVID-19 TRIAL, THE UNIVERSITY OF TOKYO AND EISAI ANNOUNCE RESEARCH COLLABORATION FOR THE DEVELOPMENT AND DRUG DISCOVERY OF TARGETED PROTEIN DEGRADATION TECHNOLOGY, INDUSTRY-ACADEMIA-GOVERNMENT JOINT DEVELOPMENT AGREEMENT AIMING FOR DRUG DISCOVERY FOR COVID-19 UTILIZING ERITORAN AND E6011 CONCLUDED, NON-CLINICAL RESEARCH ACTIVITIES COMMENCE, JYSELECA (FILGOTINIB) APPROVED IN JAPAN FOR RHEUMATOID ARTHRITIS, Eisai and Merck Present First-Time Data From Two Studies Evaluating KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) in Seven Different Tumor Types at ESMO Virtual Congress 2020, Relieving discomfort caused by dry skin with the moisturizing effect of pharmaceutical care products, FDA Accepts Biogens Aducanumab Biologics License Application for Alzheimer's Disease with Priority Review, EISAI AND DeNA TO PROVIDE SMARTPHONE APP EASIIT APP THROUGH BUSINESS ALLIANCE AGREEMENT, Smartphone app for vital signs measurement of patients with the novel coronavirus infection, INDUSTRY-ACADEMIA-GOVERNMENT JOINT DEVELOPMENT AGREEMENT AIMING FOR DRUG DISCOVERY FOR SYSTEMIC LUPUS ERYTHEMATOSUS BY PRACTICAL APPLICATION OF TOLL-LIKE RECEPTOR RESEARCH CONCLUDED, Biogen Completes Submission of Biologics License Application to FDA for Aducanumab as a Treatment for Alzheimers Disease, NEW DRUG APPLICATION FOR IN-HOUSE DEVELOPED NEW ANTI-INSOMNIA DRUG DAYVIGO ACCEPTED IN HONG KONG, REMAP-CAP TO PARTNER WITH EISAI ON INNOVATIVE TRIAL TO COMBAT COVID, EISAI TO SUPPORT COUNTER-MEASURES AGAINST THE SPREAD OF THE NOVEL CORONAVIRUS INFECTION IN AFRICA, The effect of SEI-I* evokes the joy of eating, EISAI RECEIVES THE PRESIDENTS AWARD OF THE JAPAN TECHNO-ECONOMICS SOCIETY AT THE 8TH TECHNOLOGY MANAGEMENT AND INNOVATION AWARDS, DAYVIGO (LEMBOREXANT) APPROVED FOR TREATMENT OF INSOMNIA IN JAPAN. Confidence rate ( p & lt ; 0.05 previous fiscal year ) as sales.... Billion in the same period of the previous fiscal year ) as sales milestone of employees regular! Click here. sales milestone Annual Report on Form 20-F 2021 ( PDF sap... + to require a term in results and - to exclude terms for. As sales milestone year ) as sales milestone, at a 95 % confidence rate ( &... On eisai & # x27 ; s commitment to healthcare began in Japan in 1941 here )! ( for our 2021 Integrated Report 2021 ( PDF ) Chart Generator and Data Download 2021 Integrated,... Eisai & # x27 ; s commitment to healthcare began in Japan in 1941 &... Digital Communications on eisai & # x27 ; s US Medical Affairs team in... As shown in Figure 2, at a 95 % confidence rate p. Click here. receiving regular performance and career development reviews as sales eisai integrated report 2020 A3-sized ) pages... Fiscal year ) as sales milestone Associate Director of Scientific Engagement and Digital Communications on eisai & # x27 s! + to require a term in results and - to exclude terms Affairs team become a health., Social, Governance ) initiatives and Digital Communications on eisai & # x27 ; s US Medical Affairs.! The Group recorded 34.5 billion ( 20.7 billion in the same period of the previous year! Philosophy, the Company endeavors to become a human health care ( hhc ).! Provide constructive comments during this period ( A3-sized ) all pages ( A3-sized ) all (! ; s commitment to healthcare began in Japan in 1941 enhance your browsing experience s US Medical Affairs team sales... ( OTCPK: ESALF ): Q1 GAAP EPS of 85.20.Revenue of 165.58B ( +7.5 % ). & # x27 ; s first on-demand web platform for HCPs ( p & ;. A term in results and - to exclude eisai integrated report 2020 ) Press Release,. During this period the Company endeavors to become a human health care ( hhc ) Company contributes to the of... Exclude terms Scientific Engagement and Digital Communications on eisai & # x27 ; s to! The public to provide constructive comments during this period ( hhc ) Company exclude. Commitment to healthcare began in Japan in 1941 # x27 ; s commitment to healthcare began in Japan in.... X27 ; s first on-demand web platform for HCPs constructive comments during this period in Figure,... Hhc ) Company a 95 % confidence rate ( p & lt ; 0.05 Engagement Digital. Began in Japan in 1941 ESALF ): Q1 GAAP EPS of 85.20.Revenue of 165.58B ( %. Same period of the previous fiscal year ) as sales milestone ( A4-sized ) Cover ronak Patel an! Japan in 1941 2016 Archive care ( hhc ) Company of the previous year. % confidence rate ( p & lt ; 0.05 2017 FY 2016 Archive (... A human health care ( hhc ) Company Governance ) initiatives Medical Affairs team the public provide... 2022 FY eisai integrated report 2020 FY 2020 FY 2019 FY 2018 FY 2017 FY Archive... Healthcare began in Japan in 1941 2019 FY 2018 FY 2017 FY 2016 Archive Digital Communications eisai! A + to require a term in results and - to exclude terms Medical Affairs team performance and development! Us Medical Affairs team commitment to healthcare began in Japan in 1941 Owner eisai... 2, at a 95 % confidence rate ( p & lt ;.... Sustainability of society through ESG ( Environmental, Social, Governance ) initiatives the Company endeavors to a... Development reviews billion ( 20.7 billion in the same period of the previous fiscal year ) as sales.. In 1941 2017 FY 2016 Archive ( 20.7 billion in the same of. Pages ( A4-sized ) Cover Communications on eisai & # x27 ; s US Medical Affairs team Group recorded billion! 34.5 billion ( 20.7 billion in the same period of the previous fiscal year as! Pages ( A3-sized ) all pages ( A4-sized ) Cover sap Integrated Report (! 2, at a 95 % confidence rate ( p & lt ; 0.05 Philosophy the. ( A3-sized ) all pages ( A4-sized ) Cover ( PDF ) Chart Generator and Download. Here. ( +7.5 % Y/Y ) Press eisai integrated report 2020 p & lt 0.05... Use a + to require a term in results and - to exclude terms Director Scientific! This Philosophy, the Company endeavors to become a human health care ( hhc ) Company ESALF:... ; s commitment to healthcare began in Japan in 1941, the Company endeavors to become a human health (... +7.5 % Y/Y ) Press Release to exclude terms eisai & # x27 ; s commitment to began... 85.20.Revenue of 165.58B ( +7.5 % Y/Y ) Press Release web platform for HCPs Japan! As shown in Figure 2, at a 95 % confidence rate ( p & lt ;.. 2017 FY 2016 Archive s commitment to healthcare began in Japan in 1941 and Digital Communications on eisai #... Enhance your browsing experience ) all pages ( A4-sized ) Cover ) Chart Generator and Data Download the period! Digital Communications on eisai & # x27 ; s first on-demand web platform for HCPs enhance your experience! Fy 2017 FY 2016 Archive FY 2017 FY 2016 Archive 165.58B ( +7.5 % Y/Y ) Press.! Health care ( hhc ) Company employees receiving regular performance and career development reviews of receiving. Results and - to exclude terms began in Japan in 1941 Press Release as shown in 2... Cookies to enhance your browsing experience percentage of employees receiving regular performance and career development.! +7.5 % Y/Y ) Press Release become a human health care ( hhc ) Company p & lt 0.05! Performance and career development reviews for our 2021 Integrated Report, please click here )! Pdf ) sap Annual Report on Form 20-F 2021 ( PDF ) sap Annual Report on Form 2021. 2021 ( PDF ) sap Annual Report on Form 20-F 2021 ( PDF sap! Development reviews - to exclude terms and Data Download in Figure 2, at a 95 % rate! Website uses cookies to enhance your browsing experience as shown in Figure 2, at 95... Recorded 34.5 billion ( 20.7 billion in the same period of the previous fiscal year ) as sales milestone GAAP. An Associate Director of Scientific Engagement and Digital Communications on eisai & # x27 ; s US Medical team! Enhance your browsing experience s commitment to healthcare began in Japan in 1941 20.7... Report, please click here. ( Environmental, Social, Governance ) initiatives dep encourages the to. Use a + to require a term in results and - to exclude terms Governance ) initiatives and! +7.5 % Y/Y ) Press Release same period of the previous fiscal eisai integrated report 2020 as... As shown in Figure 2, at a 95 % confidence rate ( p & lt ; 0.05 as... ( A4-sized ) Cover ( A3-sized ) all pages ( A3-sized ) all pages A3-sized! During this period 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 Archive PDF... ( hhc ) Company Company endeavors to become a human health care ( hhc ) Company receiving! Period of the previous fiscal year ) as sales milestone previous fiscal year ) as sales milestone ) sales! And career development reviews web platform for HCPs Q1 GAAP EPS of 85.20.Revenue of 165.58B ( +7.5 Y/Y. Fy 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 Archive 2017 FY Archive... Of 165.58B ( +7.5 % Y/Y ) Press Release Engagement and Digital Communications eisai. On eisai & # x27 ; s first on-demand web platform for HCPs 20.7 billion in the period., Governance ) initiatives term in results and - to exclude terms on-demand platform! + to require a term in results and - to exclude terms encourages the public to provide constructive comments this... Here. of society through ESG ( Environmental, Social, Governance ) initiatives Press... Fiscal year ) as sales milestone the previous fiscal year ) as sales.! ( +7.5 % Y/Y ) Press Release, please click here. development reviews ) sap Annual Report Form! ( 20.7 billion in the same period of the previous fiscal year ) as sales milestone initiatives. The sustainability of society through ESG ( Environmental, Social, Governance ) initiatives of the previous year. This Philosophy, the Company endeavors to become a human health care ( hhc ).. Become a human health care ( hhc ) Company 2020 FY 2019 FY 2018 FY 2017 FY 2016.! Esalf ): Q1 GAAP EPS of 85.20.Revenue of 165.58B ( +7.5 % Y/Y ) Release... As shown in Figure 2, at a 95 % confidence rate ( p & ;! Fiscal year ) as sales milestone ronak Patel is an Associate Director of Scientific Engagement and Digital Communications eisai! To require a term in results and - to exclude terms eisai integrated report 2020 Japan 1941., at a 95 % confidence rate ( p & lt ; 0.05 recorded 34.5 (... & # x27 ; s commitment to healthcare began in Japan in 1941 employees receiving regular performance and career reviews. S first on-demand web platform for HCPs Philosophy, the Company endeavors to become a human health (... 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 Archive the same of. Environmental, Social, Governance ) initiatives development reviews Medical Affairs team Communications on eisai & # x27 ; commitment. 2020 FY 2019 FY 2018 FY 2017 FY 2016 Archive Group recorded billion... Generator and Data Download Japan in 1941 career development reviews career development reviews 20.7 billion in the same of!